Resultados clínicos del tratamiento de ojo seco moderado a severo con insulina tópica
dc.contributor.advisor | Peña, Fernando Yaacov | |
dc.contributor.advisor | Laverde Cubides, Christian Armando | |
dc.contributor.author | Palacio Varona, Juliana | |
dc.contributor.orcid | Palacio Varona, Juliana [0000-0003-0572-7762] | |
dc.date.accessioned | 2024-08-02T13:58:15Z | |
dc.date.available | 2024-08-02T13:58:15Z | |
dc.date.issued | 2024-05 | |
dc.description.abstract | Determinar la eficacia del tratamiento del ojo seco moderado a severo con insulina tópica. MATERIALES Y METODOS: Mediante un estudio descriptivo retrospectivo, se realizó una revisión de historias clínicas de mayores de 18 años tratados con insulina tópica y análisis comparativo en la mejoría de los marcadores de la homeostasis y de la encuesta Ocular Surface Disease Index (OSDI). Se ejecutó análisis de varianza (ANOVA) y de correlación de Pearson-Spearman. | |
dc.description.abstractenglish | To determine the treatment effectiveness of threating of treating moderate to severe dry eye with topical insulin MATERIALS AND METHOD: Through a retrospective descriptive study, a review of medical records of patients over 18 years of age treated with topical insulin and a comparative analysis was carried out on the improvement of homeostasis markers and the results of the Ocular Surface Disease Index (OSDI) survey. An analysis of variance (ANOVA) and Pearson-Spearman correlation were performed. | |
dc.description.degreelevel | Especialización | spa |
dc.description.degreename | Especialista en Oftalmología | spa |
dc.description.sponsorship | Hospital Simón Bolívar | |
dc.format.mimetype | application/pdf | |
dc.identifier.instname | instname:Universidad El Bosque | spa |
dc.identifier.reponame | reponame:Repositorio Institucional Universidad El Bosque | spa |
dc.identifier.repourl | repourl:https://repositorio.unbosque.edu.co | |
dc.identifier.uri | https://hdl.handle.net/20.500.12495/12798 | |
dc.language.iso | es | |
dc.publisher.faculty | Facultad de Medicina | spa |
dc.publisher.grantor | Universidad El Bosque | spa |
dc.publisher.program | Especialización en Oftalmología | spa |
dc.relation.references | 1. Clayton JA. Dry eye. N Engl J Med. 2018;378(23):2212–23. | |
dc.relation.references | 2. Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf [Internet]. 2017;15(3):539–74. Available from: http://dx.doi.org/10.1016/j.jtos.2017.05.001 | |
dc.relation.references | 3. O’Neil EC, Henderson M, Massaro-Giordano M, Bunya VY. Advances in dry eye disease treatment. Curr Opin Ophthalmol. 2019;30(3):166–78. | |
dc.relation.references | 4. Akpek EK, Amescua G, Farid M, Garcia-Ferrer FJ, Lin A, Rhee MK, et al. Dry Eye Syndrome Preferred Practice Pattern®. Ophthalmology. 2019;126(1):P286–334. | |
dc.relation.references | 5. Cubayachi C, Lemos CN, Pereira F, Dias K, Herculano RD, de Freitas O, et al. Silk fibroin films stabilizes and releases bioactive insulin for the treatment of corneal wounds. Eur Polym J [Internet]. 2019;118(January):502–13. Available from: https://doi.org/10.1016/j.eurpolymj.2019.06.022 | |
dc.relation.references | 6. Diaz-Valle D, Burgos-Blasco B, Gegundez-Fernandez JA, Garcia-Caride S, Puebla-Garcia V, Peña-Urbina P, et al. Topical insulin for refractory persistent corneal epithelial defects. Eur J Ophthalmol. 2020; | |
dc.relation.references | 7. Subcomité de Epidemiologia de DEWS. DEWS Definición y clasificación de la enfermedad del ojo seco. Ocul Surf. 2007;5(2):75–92. | |
dc.relation.references | 8. Amparo F, Schaumberg D, Dana R. Comparison of Two Questionnaires for Dry Eye Symptom Assessment: The Ocular Surface Disease Index and the Symptom Assessment iN Dry Eye. Opthalmology. 2016;176(1):139–48. | |
dc.relation.references | 9. Wang AL, Weinlander E, Metcalf BM, Barney NP, Gamm DM, Nehls SM, et al. Use of Topical Insulin to Treat Refractory Neurotrophic Corneal Ulcers. Cornea. 2017;36(11):1426–8. | |
dc.relation.references | 10. Tong CM, Iovieno A, Yeung SN. Topical insulin for neurotrophic corneal ulcers. Can J Ophthalmol [Internet]. 2020;55(5):e170–2. Available from: https://doi.org/10.1016/j.jcjo.2020.04.001 | |
dc.relation.references | 11. Aniah Azmi N, Bastion MLC. Short-Term Results of Trial of Topical Insulin for Treatment of Dry Eyes in Diabetics. Eye Contact Lens. 2020;46(January):S25–32. | |
dc.relation.references | 12. Ghiasi Z, Gray T, Tran P, Dubielzig R, Murphy C, McCartney DL, et al. The effect of topical substance-p plus insulin-like growth factor-1 (IGF-1) on epithelial healing after photorefractive keratectomy in rabbits. Transl Vis Sci Technol. 2018;7(1):1–7. | |
dc.relation.references | 13. Serrano-Giménez R, Contreras-Macías E, García-Bernal A, Fobelo-Lozano MJ. Insulina tópica en el tratamiento de úlcera corneal refractaria en un paciente no diabético: a propósito de un caso. Farm Hosp. 2020;44(6):297–9. | |
dc.relation.references | 14. Bremond-Gignac D, Daruich A, Robert MP, Chiambaretta F. Recent innovations with drugs in clinical trials for neurotrophic keratitis and refractory corneal ulcers. Expert Opin Investig Drugs [Internet]. 2019;28(11):1013–20. Available from: https://doi.org/10.1080/13543784.2019.1677605 | |
dc.relation.references | 15. CIMA AE de medicamentos y productos sanitarios. Ficha técnica o resumen de las características del producto ACTRAPID 100UI/ML Solución inyectable en un via. Agencia Eur Medicam [Internet]. 2014;1–33. Available from: ec.europa.eu/health/documents/community.../anx_130850_es.pdf | |
dc.relation.references | 16. AEMPS. Ficha técnica Humulina Regular. Agencia Española Medicam y Prod Sanit [Internet]. 2015;8. Available from: https://cima.aemps.es/cima/pdfs/es/ft/56317/56317_ft.pdf | |
dc.relation.references | 17. Bastion MLC, Ling KP. Topical insulin for healing of diabetic epithelial defects?: A retrospective review of corneal debridement during vitreoretinal surgery in Malaysian patients. Med J Malaysia. 2013;68(3):208–16. | |
dc.relation.references | 18. Fai S, Ahem A, Mustapha M, Mohd Noh UK, Catherine Bastion ML. Randomized controlled trial of topical insulin for healing corneal epithelial defects induced during vitreoretinal surgery in diabetics. Asia-Pacific J Ophthalmol. 2017;6(5):418–24. | |
dc.relation.references | 19. Burgos-Blasco B, Diaz-Valle D, Rego-Lorca D, Perez-Garcia P, Puebla-Garcia V, Fernandez-Vigo JI, et al. Topical insulin, a novel corneal epithelial regeneration agent in dry eye disease. Eur J Ophthalmol. 2023;1–7. | |
dc.relation.references | 20. Salud M de. Resolución Numero 8430 de 1993. 1993;8430:1–10. | |
dc.relation.references | 21. Manzini JL. Declaración De Helsinki: Principios Éticos Para La Investigación Médica Sobre Sujetos Humanos. Acta Bioeth. 2000;6(2):321–34. | |
dc.relation.references | 22. Cubayachi C, Lemos CN, Pereira F, Dias K, Herculano RD, de Freitas O, et al. Silk fibroin films stabilizes and releases bioactive insulin for the treatment of corneal wounds. Eur Polym J [Internet]. 2019;118(June):502–13. Available from: https://doi.org/10.1016/j.eurpolymj.2019.06.022 | |
dc.relation.references | 23. Diaz-Valle D, Burgos-Blasco B, Gegundez-Fernandez JA, Garcia-Caride S, Puebla-Garcia V, Peña-Urbina P, et al. Topical insulin for refractory persistent corneal epithelial defects. Eur J Ophthalmol. 2021;31(5):2280–6. | |
dc.rights | Atribución-NoComercial 4.0 Internacional | en |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
dc.rights.accessrights | http://purl.org/coar/access_right/c_abf2 | |
dc.rights.local | Acceso abierto | spa |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject | Defecto epitelial | |
dc.subject | Insulina tópica | |
dc.subject | Ulcera corneal | |
dc.subject | Queratopatia | |
dc.subject | Ulcera corneal neurotrófica | |
dc.subject | Ojo seco | |
dc.subject.keywords | Epithelial defect | |
dc.subject.keywords | Topical insulin | |
dc.subject.keywords | Corneal ulcer | |
dc.subject.keywords | Ketratophaty | |
dc.subject.keywords | Neurotrophic corneal ulcer | |
dc.subject.keywords | Dry eye | |
dc.subject.nlm | WW 100 | |
dc.title | Resultados clínicos del tratamiento de ojo seco moderado a severo con insulina tópica | |
dc.title.translated | Clinical results of topical insulin treatment of moderate to severe dry eye | |
dc.type.coar | https://purl.org/coar/resource_type/c_7a1f | |
dc.type.coarversion | https://purl.org/coar/version/c_ab4af688f83e57aa | |
dc.type.driver | info:eu-repo/semantics/bachelorThesis | |
dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | |
dc.type.local | Tesis/Trabajo de grado - Monografía - Especialización | spa |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- Trabajo de grado.pdf
- Tamaño:
- 578.94 KB
- Formato:
- Adobe Portable Document Format
Bloque de licencias
1 - 4 de 4
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.95 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción:
No hay miniatura disponible
- Nombre:
- Carta de autorización.pdf
- Tamaño:
- 151.71 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
No hay miniatura disponible
- Nombre:
- Anexo 1. Formularios.pdf
- Tamaño:
- 524.05 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
No hay miniatura disponible
- Nombre:
- Anexo 1 Probatus.pdf
- Tamaño:
- 168.49 KB
- Formato:
- Adobe Portable Document Format
- Descripción: